The Intestinal Ecosystem
The mammalian microbiota comprises several hundred different bacterial species many of which have a beneficial effect on the host. For example they are involved in preventing colonization of the gut by pathogens and maintaining the gut mucosal immunity (85). The gut microbiota is more abundant in the large intestine of mammals, with densities rising to over 10 11 organisms/g intestinal contents (84, 86). The number of bacterial cells in the entire gut exceeds the number of eukaryotic cells in the host, but under normal circumstance they coexist without any adverse effect on the host. The influence of the resident microflora on mucosal immune function and gut health has become an area of scientifical and clinical importance (22, 26). There is an active dialogue between the commensal microorganisms and the host mucosal immune system (21, 48). This crosstalk elicits different host responses to commensal and pathogenic bacteria. Commensal bacteria may even share molecular patterns recognized by toll-like receptors, which can recognize patterns associated mainly with pathogens. However, the mucosal immune system of the healthy intestine allows the persistence of this microbiota associated to the intestine and avoids immunological tolerance and maintaining the intestinal homeostasis. Now there is acceptance of the concept that oral tolerance is not generated by commensal intestinal bacteria; the host would ignore or fail to recognize the presence of indigenous microorganisms (49). The healthy host is able to elicit a good mucosal immune response against luminal antigens and to maintain a "physiological state of inflammation" in the gut, but it is also capable of responding to invading commensal organisms or pathogens. In the healthy host the penetration of the commensal bacteria is usually prevented by the barrier afforded by the intestinal epithelium and the immune cells associated with mucosa which are highly adapted to the presence of the normal microbiota (71) . The signals sent by these microorganisms prevent their penetration and maintains them outside the intestinal tissue. If
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on October 29, 2017 by guest http://cvi.asm.org/ Downloaded from the commensal microorganisms invade the host tissues, the innate immune mechanisms contribute to their rapid clearance, but when pathogens enter the intestine, innate and adaptative mechanisms are coordinately stimulated to respond the danger signals (38, 60) .
Although mucosal epithelial tissues form an efficient barrier that prevents the entrance of the environmental pathogens and the external antigens into the host internal milieu, mucosal tissues represent the main sites of infection by pathogens. Many attempts have been made to understand the gut immunomodulation by pathogenic bacteria, but not the mechanisms involved in the modulation of the gut immune system by commensal bacteria and by nonpathogenic microorganisms present in many foods included in the daily diet.
Non-pathogenic probiotic bacteria
The interest in the gut microflora, led to numerous investigations to demonstrate that there are beneficial and potentially harmful microorganisms in the intestine and that the one could be used to influence the activities of the other. These findings led to the "probiotic"
concept, originally used to describe microbial feed supplements which stimulate the growth of farm animals. Now, the use of live microbes as dietary supplements has been extended to the human. Many definitions of probiotics have been published, starting from Fuller, who defined a probiotic "a live microbial feed supplement which beneficially affects the host by improving its intestinal microbial balance" (25). A more recent one from FAO/WHO is:
"Live microorganisms that when being administered in appropriate dose, they confer a benefit of health to the receiver." Some of the health benefits which have been claimed for probiotics are: improvement of the normal microflora (2), prevention of infectious diseases (3, 6, 9, 11, 19, 65, 83) The ability of probiotics to prevent or reverse several pathological conditions (27) by stimulating the immune system and all the scientific evidences in the immune system activation by probiotics indicates that the ability to generate an immune response should be included in the probiotic definition. Consequently we suggest probiotics should be defined as:
"live microorganisms, that when includes in foods can influence the composition and activity of the gut microbiota, modulate the inflammatory response, improve the non-specific intestinal barrier, and reinforce or modulate the mucosal and the systemic immune response".
This definition ascribes to the probiotic microorganisms in the dietary supplement the potential for the prevention of infections, tumor growth or other systemic pathologies including effects in distant mucosal sites from the gut as in the bronchus (14, 69), mammary glands (15, 16) and urogenital tract (74, 91) . However, for the best use of these microorganisms, the mechanisms by which they work should be understood. We believe that the selection of an appropriate probiotic strain for its inclusion in a probiotic preparation should be made on the basis of its capacity to induce an improved gut immune response without modification of the intestinal homeostasis. To achieve this task, probiotic strains should have the following properties: a) high cell viability, thus they must be resistant to low pH and bile acids; b) ability to persistence in the intestine even if, the probiotic strain cannot colonize the gut; continuous administration may be necessary c) the adhesion to the gut 
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. The quantity of these microorganisms to achieve the adjuvant effect in the mucosal or systemic immune response was 1x10 8 -1x10 9 C.F.U. / day (68, 90).
In the analyzes of the profile of cytokine induced by some lactic acid bacteria, we observed the most remarkable effect was the increase in the TNFα, IFNγ and in the regulatory cytokine IL-10 for all the probiotic strains assayed. This effect was obtained without increasing the inflammatory response and only slight increasing the cellularity was determined. However The proposed model on the mechanisms induced by probiotic bacteria from our studies show at least in part the scientific basis of the way in which the probiotics work. This knowledge would be also useful to influence the gut immune system in pathological conditions.
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control). (B)
Ex vivo assay. IL-6 production by SIEC isolated from BALB/c mice that received viable culture (1x10 8 C.F.U / ml/day) of L. casei isolated from human faeces and L. helveticus isolated from cheese, during different period of time (2, 5 or 7 days). (C) IL-6 production by SIEC treated or not with anti-TLR2 and anti-TLR4 antibodies before they were stimulated with the bacterial strains or with LPS. LPS was used as a positive control. * Significantly different from the corresponding control value (P< 0.05). 
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Figure 1
The scanning electron micrograph show the interaction of Lactobacillus helveticus R389 with the intestinal epithelial cells (IEC) obtained from the small intestine of BALB/c mice. The epithelial cells were recovered from the small intestine after digestion with collagenase in adequate culture medium. Lactobacillus helveticus suspension (10 12 CFU/ml) was added to IEC isolated. After bacterium contact with IEC during 2 hours, the samples were processed for scanning electron micrograph. Magnification 6000X. 
